No results for ‘’
M K Proteins Ltd
₹4.91
(1.01%)
Thu, 25 Jun 2026, 00:11 am
Process Industries
Agricultural Commodities/Milling
24.5KM K Proteins EV/EBITDA Ratio
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Price to earnings ratio | 16.39 | 3.19 | 7.84 | 83.53 | 33.08 | 27 |
| Price to book ratio | 1.57 | 1.13 | 2.02 | 18.32 | 6.07 | 3.26 |
| Price to sales ratio | 0.15 | 0.11 | 0.31 | 2.90 | 1.51 | 0.85 |
| Price to cash flow ratio | 0 | 5.98 | 0 | 0 | 11.78 | 0 |
| Enterprise value | 60.23Cr | 58.28Cr | 117Cr | 959Cr | 391Cr | 265Cr |
| Enterprise value to EBITDA ratio | 12.45 | 3.64 | 7.37 | 54.05 | 22.63 | 20.69 |
| Debt to equity ratio | 1.61 | 0.86 | 0.93 | 0.91 | 0.33 | 0.56 |
| Return on equity % | 0 | 43.03 | 29.54 | 24.44 | 20.14 | 12.87 |
M K Proteins Ltd Enterprise Value to EBITDA Ratio
The M K Proteins Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate M K Proteins Ltd's valuation, profitability, and overall financial performance. Tracking the M K Proteins Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
M K Proteins Ltd (NSE: MKPL, BSE: 543919) is currently trading at ₹4.91, with a market capitalization of ₹186.94Cr. As a leading company in the Process industries sector and Agricultural commodities/Milling industry, monitoring the M K Proteins Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
M K Proteins Ltd Enterprise Value to EBITDA Ratio Current Value
The current M K Proteins Ltd Enterprise Value to EBITDA Ratio stands at 20.69.
The M K Proteins Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
M K Proteins Ltd Enterprise Value to EBITDA Ratio Historical Trend
The M K Proteins Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 20.69
- 2023: 22.63
- 2022: 54.05
- 2021: 7.37
- 2020: 3.64
The decline in M K Proteins Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What M K Proteins Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The M K Proteins Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of M K Proteins Ltd.
M K Proteins Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The M K Proteins Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking M K Proteins Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of M K Proteins Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.